Chest Pain
Revascularization rates higher with ‘CT first’ diagnosis of chest pain
Read-world data showed that more patients underwent subsequent revascularization after “CT first” evaluation for chest pain vs. other functional testing strategies, researchers reported.
Prehospital rule-out of NSTEACS cost-effective vs. ED admission at 1 year
Prehospital rule-out of non-ST-segment elevation ACS with risk assessment and a single troponin test led to lower health care cost with similarly low 1-year outcomes vs. rule-out in the ED, results of the ARTICA trial show.
Risk for death, heart events rises when combining erectile dysfunction drugs, nitrates
Men with CAD taking nitrates for chest pain plus a PDE5 inhibitor for erectile dysfunction were at greater risk for death or major adverse CV events compared with men taking nitrates alone, Swedish registry data show.
Comorbidities muddy acute MI diagnosis in patients with cancer presenting with chest pain
Patients with a history of or active cancer had a higher rate of acute MI when presenting to the ED with chest pain, a speaker reported.
Chest pain 1 year after heart attack points to worse long-term survival
Moderate to extreme chest pain reported 1 year after an MI may be indicative of increased mortality risk, according to a study published in the Journal of the American Heart Association.
VIDEO: ‘There is a role for both’ anatomical, functional testing in cardiac diagnosis
ARLINGTON, Texas — In this Healio video exclusive, Healio | Cardiology Today Editorial Board Member Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC, discusses how anatomical and functional testing both have a role in cardiac diagnosis.
Coronary CT may be best diagnostic strategy when evaluating stable chest pain
For adults with stable chest pain, coronary CTA may be as useful as direct invasive coronary angiography and may be the best diagnostic strategy vs. stress testing and single-photon emission CT myocardial perfusion imaging, data show.
Invasive endotyping clarifies unexplained chest pain, but no improvement in symptom burden
In patients with angina with nonobstructive CAD, invasive testing increased the likelihood of an angina endotype diagnosis and improved treatment satisfaction compared with controls, but did not improve angina burden, researchers reported.
Most US hospitals not using high-sensitivity cardiac troponin assays
National registry data show only one-third of U.S. hospitals are using high-sensitivity cardiac troponin assays as of September 2021, with most continuing to use less sensitive cardiac troponin assays despite guideline recommendations.
Among patients with non-dialysis CKD, 83% report fatigue
Symptom prevalence ranged among patients with non-dialysis chronic kidney disease, with 24% reporting chest pain and 83% reporting fatigue, according to data published in the Clinical Journal of the American Society of Nephrology.